Select your local website
Australia Belgium Canada China Denmark Deutschland España France Italia Lietuva Nederlands Portugal Russia Sweden Turkey United Kingdom United States

Middle East Respiratory Syndrome (MERS-CoV)

Infection prevention and control measures are critical to prevent the possible spread of MERS-CoV in health care facilities.
To date 701 laboratory-confirmed cases of infection with MERS-CoV including at least 249 reported deaths have been reported globally  to the World Health Organisation (WHO).  Although as the name suggests this has mainly centred upon the Middle East Region , there have reports from around the world.  The upcoming festivals and prilgimages will vastly increase the movement of people into and out of the region which could further exacerbate the spread of the infection.
 
WHO's most recent recommendation is:
"Infection prevention and control measures are critical to prevent the possible spread of MERS-CoV in health care facilities. It is not always possible to identify patients with MERS-CoV early because like other respiratory infections, the early symptoms of MERS-CoV are non-specific. Therefore, health-care workers should always apply standard precautions consistently with all patients, regardless of their diagnosis. Droplet precautions should be added to the standard precautions when providing care to patients with symptoms of acute respiratory infection; contact precautions and eye protection should be added when caring for probable or confirmed cases of MERS-CoV infection; airborne precautions should be applied when performing aerosol generating procedures.(1)"



The Intersurgical breathing filter range and FiltaMaskā„¢ medium concentration mask and can assist in the reduction of cross contamination between patients, staff and equipment.



(1) WHO website 16-6-14 http://www.who.int/csr/don/2014_06_16_mers/en/
 

Featured products

© Intersurgical Ltd, 2019
Crane House, Molly Millars Lane, Wokingham, Berkshire, RG41 2RZ, UK
+44 (0) 118 9656 300